SuspendedNANCT06985862

Development of Artificial Intelligence Tools for the Detection of Stress Markers and Consideration of Stress States in the Monitoring of Subjects With Type 1 Diabetes

Sponsor: Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

Trial Details

Condition	Diabetes Type 1
Intervention	Voice recording 4 times a day
Phase	NA
Status	Suspended
Participants	35
Est. Completion	1 Dec 2026
Last Updated	8 May 2026

Primary Outcome

Voice recording of participants

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Patient who has signed the SMART-T1D free and informed consent form * Patient able to speak and read French Exclusion Criteria: * Mute patient. * Patient with severe speech problems that may prevent voice recordings from being made.

Trial Sites

Countries

France

View Registry Entry

Related Analysis

Voice-Based AI Stress Detection Trial in Type 1 Diabetes Suspended — Implications for Digital Health Monitoring

French researchers are developing voice-based AI tools to detect stress in type 1 diabetes patients, though the SMART-T1D trial is currently suspended. This innovative approach could revolutionise diabetes monitoring by using daily voice recordings to identify stress patterns affecting blood glucose control.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service